0001844239-21-000001.txt : 20210208 0001844239-21-000001.hdr.sgml : 20210208 20210208100704 ACCESSION NUMBER: 0001844239-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210208 DATE AS OF CHANGE: 20210208 EFFECTIVENESS DATE: 20210208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Interline Therapeutics, Inc. CENTRAL INDEX KEY: 0001844239 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-388699 FILM NUMBER: 21599256 BUSINESS ADDRESS: STREET 1: 601 CALIFORNIA STREET STREET 2: SUITE 600 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 BUSINESS PHONE: 415-787-6009 MAIL ADDRESS: STREET 1: 601 CALIFORNIA STREET STREET 2: SUITE 600 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 D 1 primary_doc.xml X0708 D LIVE 0001844239 Interline Therapeutics, Inc. 601 CALIFORNIA STREET SUITE 600 SAN FRANCISCO CA CALIFORNIA 94108 415-787-6009 DELAWARE None None Corporation true 2021 Zachary Sweeney c/o Interline Therapeutics, Inc. Suite 600 San Francisco CA CALIFORNIA 94108 Executive Officer Director Vikram Bajaj c/o Interline Therapeutics, Inc. Suite 600 San Francisco CA CALIFORNIA 94108 Director James Tananbaum c/o Interline Therapeutics, Inc. Suite 600 San Francisco CA CALIFORNIA 94108 Director Other Health Care Decline to Disclose 06b false 2021-01-27 false true false 0 10100000 10100000 0 false 3 0 0 0 false Interline Therapeutics, Inc. /s/ Zachary Sweeney Zachary Sweeney President and Chief Executive Officer 2021-02-08